Request Deal Involvement
Enavate Sciences led a $118m Series B funding round in Zenas BioPharma.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Principals
bidder
AGENT CAPITAL
target
ZENAS BIOPHARMA
bidder
WELLINGTON MANAGEMENT
bidder
PERCEPTIVE ADVISORS LLC
bidder
ROCK SPRINGS CAPITAL
bidder
ENAVATE SCIENCES
bidder
SUPERSTRING CAPITAL
bidder
PIVOTAL BIOVENTURE PARTNERS LLC
bidder
FAIRMOUNT FUNDS MANAGEMENT
bidder
LONGITUDE CAPITAL MANAGEMENT CO LLC
bidder
VIVO CAPITAL LLC
bidder
QUAN VENTURE FUND
bidder
XENCOR
bidder
TELLUS BIOVENTURES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite